TS

Trinity St James's Cancer Institute at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Trinity St James's Cancer Institute takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on non-small cell lung cancer, from early-stage to metastatic disease. It debates giving immunotherapy only before surgery versus both before and after surgery in early disease.

OrganizationESMO 2026 Attendance
TS
Trinity St James's Cancer Institute
Dublin, Ireland
Cancer centre & hospital
Joint cancer institute of Trinity College Dublin and St James's Hospital in Dublin, Ireland.
Satellite
Sun Oct 25
13:20–14:05
Neoadjuvant vs Perioperative Immunotherapy: An Expert Clinical Debate
BeOne Medicines - Data, Debate, and New Directions in the NSCLC Continuum:​From Early-Stage Immunotherapy to New Modalities in Advanced Disease · with University Hospital Cologne, University of Turin, Hospital Universitario Puerta de Hierro Majadahonda +1 more
Lung & thoracic cancers
Chair
Mon Oct 26
08:30–10:00
Proffered paper 2: NSCLC, metastatic
with European Institute of Oncology (IEO)
Lung & thoracic cancers
Talk
Tue Oct 27
10:00–10:20
NSCLC, metastatic
Scientific Congress Highlights 2

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Trinity St James's Cancer Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction